A federal judge on Monday threw out a $96 million jury verdict against genetic testing company CareDX that rival Natera had ...

Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...

Genetic testing company Natera (NASDAQ:NTRA). will be announcing earnings results tomorrow after market close. Here’s what to ...

Natera Inc (NASDAQ:NTRA) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue ...

Natera (NTRA) announced that its Signatera test has met coverage requirements from the Centers for Medicare & Medicaid Services’ Molecular ...

Natera (NASDAQ:NTRA – Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced that its Signatera test has met coverage requirements from the Centers for Medicare & Medicaid Services' (CMS) ...

Learn more about whether Insmed Incorporated or Natera, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high- ...

The global Liquid Biopsy Market, valued at US$5.9 billion in 2023, is forecasted to grow at a robust CAGR of 11.9%, reaching ...

Columbia Large Cap Growth Fund Institutional Share Class Shares returned 5.71% for Q4 2024. Click here to read the full ...

Columbia Select Large Cap Equity Fund Institutional Class shares returned 3.31% for the three months ending 12/31/2024. Click ...